These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 36703555)

  • 21. Nano-sized drug delivery systems to potentiate the immune checkpoint blockade therapy.
    Shim MK; Song SK; Jeon SI; Hwang KY; Kim K
    Expert Opin Drug Deliv; 2022 Jun; 19(6):641-652. PubMed ID: 35603410
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synergistic Reinforcing of Immunogenic Cell Death and Transforming Tumor-Associated Macrophages Via a Multifunctional Cascade Bioreactor for Optimizing Cancer Immunotherapy.
    Huang C; Lin B; Chen C; Wang H; Lin X; Liu J; Ren Q; Tao J; Zhao P; Xu Y
    Adv Mater; 2022 Dec; 34(51):e2207593. PubMed ID: 36245299
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chemotherapeutic drug-induced immunogenic cell death for nanomedicine-based cancer chemo-immunotherapy.
    Jiang M; Zeng J; Zhao L; Zhang M; Ma J; Guan X; Zhang W
    Nanoscale; 2021 Oct; 13(41):17218-17235. PubMed ID: 34643196
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunogenic Cell Death: An Emerging Target in Gastrointestinal Cancers.
    Chiaravalli M; Spring A; Agostini A; Piro G; Carbone C; Tortora G
    Cells; 2022 Sep; 11(19):. PubMed ID: 36230995
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Boosting Checkpoint Immunotherapy with Biomaterials.
    Liu L; Pan Y; Zhao C; Huang P; Chen X; Rao L
    ACS Nano; 2023 Feb; 17(4):3225-3258. PubMed ID: 36746639
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeting immunogenic cell stress and death for cancer therapy.
    Galluzzi L; Guilbaud E; Schmidt D; Kroemer G; Marincola FM
    Nat Rev Drug Discov; 2024 Jun; 23(6):445-460. PubMed ID: 38622310
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Local Drug Delivery Techniques for Triggering Immunogenic Cell Death.
    Ren E; Wang Y; Liang T; Zheng H; Shi J; Cheng Z; Li H; Gu Z
    Small Methods; 2023 Sep; 7(9):e2300347. PubMed ID: 37259275
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Local biomaterials-assisted cancer immunotherapy to trigger systemic antitumor responses.
    Chen Q; Chen M; Liu Z
    Chem Soc Rev; 2019 Nov; 48(22):5506-5526. PubMed ID: 31589233
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multifunctional carbon monoxide nanogenerator as immunogenic cell death drugs with enhanced antitumor immunity and antimetastatic effect.
    Xiao X; Liang S; Zhao Y; Pang M; Ma P; Cheng Z; Lin J
    Biomaterials; 2021 Oct; 277():121120. PubMed ID: 34508956
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nanoparticle-Mediated Immunogenic Cell Death Enables and Potentiates Cancer Immunotherapy.
    Duan X; Chan C; Lin W
    Angew Chem Int Ed Engl; 2019 Jan; 58(3):670-680. PubMed ID: 30016571
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nanomedicine to aid immunogenic cell death (ICD)-based anticancer therapy.
    Demuynck R; Engelen Y; Skirtach AG; De Smedt SC; Lentacker I; Krysko DV
    Trends Cancer; 2024 Jun; 10(6):486-489. PubMed ID: 38553361
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Progress in advanced nanotherapeutics for enhanced photodynamic immunotherapy of tumor.
    Wei X; Song M; Jiang G; Liang M; Chen C; Yang Z; Zou L
    Theranostics; 2022; 12(12):5272-5298. PubMed ID: 35910806
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nanoscale Metal-Organic Frameworks for Cancer Immunotherapy.
    Ni K; Luo T; Nash GT; Lin W
    Acc Chem Res; 2020 Sep; 53(9):1739-1748. PubMed ID: 32808760
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Eliciting Immunogenic Cell Death via a Unitized Nanoinducer.
    Dai Z; Tang J; Gu Z; Wang Y; Yang Y; Yang Y; Yu C
    Nano Lett; 2020 Sep; 20(9):6246-6254. PubMed ID: 32786942
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In Vitro Veritas: From 2D Cultures to Organ-on-a-Chip Models to Study Immunogenic Cell Death in the Tumor Microenvironment.
    Krysko DV; Demuynck R; Efimova I; Naessens F; Krysko O; Catanzaro E
    Cells; 2022 Nov; 11(22):. PubMed ID: 36429133
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Current status of nanoparticle-mediated immunogenic cell death in cancer immunotherapy.
    Hiep Tran T; Thu Phuong Tran T
    Int Immunopharmacol; 2024 Dec; 142(Pt A):113085. PubMed ID: 39276455
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Crizotinib prodrug micelles co-delivered doxorubicin for synergistic immunogenic cell death induction on breast cancer chemo-immunotherapy.
    Liang Q; Lan Y; Li Y; Cao Y; Li J; Liu Y
    Eur J Pharm Biopharm; 2022 Aug; 177():260-272. PubMed ID: 35863668
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Smart Nanovesicle-Mediated Immunogenic Cell Death through Tumor Microenvironment Modulation for Effective Photodynamic Immunotherapy.
    Yang W; Zhang F; Deng H; Lin L; Wang S; Kang F; Yu G; Lau J; Tian R; Zhang M; Wang Z; He L; Ma Y; Niu G; Hu S; Chen X
    ACS Nano; 2020 Jan; 14(1):620-631. PubMed ID: 31877023
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Paraptosis Inducer to Effectively Trigger Immunogenic Cell Death for Metastatic Tumor Immunotherapy with IDO Inhibition.
    Zheng RR; Zhao LP; Huang CY; Cheng H; Yang N; Chen ZX; Cai H; Zhang W; Kong RJ; Li SY
    ACS Nano; 2023 Jun; 17(11):9972-9986. PubMed ID: 37200049
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunogenic cell death (ICD)-inducers in non-small-cell lung carcinoma (NSCLC): current knowledge and future perspective.
    Kashefizadeh A; Kazemizadeh H
    Clin Transl Oncol; 2023 Feb; 25(2):316-322. PubMed ID: 36180811
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.